Stratagene, Third Wave pharmacogenetics news

STGN said a jury in the U.S. District Court for the Western District of Wisconsin ruled that TWTI's U.S. Patents Nos. 6,090,543 and 6,348,314 are valid and are infringed by certain parts of STGN's FullVelocity technology. The patents cover invasive cleavage structure chemistry for nucleic acid analysis. The jury will now hear arguments with respect to damages, STGN said. ...